Skip to content

LeMaitre Vascular LMAT Preferred Stock

Preferred Stock at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
$0
Penumbra logo
PenumbraPEN
$0
ICU Medical logo
ICU MedicalICUI
$0

Other financials

Income statement

See full
Revenue$66.6M+11.2%
Gross profit$48.4M+16.8%
Operating income$17.8M+40.8%
Net income$15.7M+42.4%
EPS (diluted)$0.68+41.7%

Balance sheet

See full
Cash & equivalents$26.9M+6.0%
Total debt$20.9M+20.6%
Total equity$406.6M+17.0%
Total assets$629.5M+13.2%

Cash flow

See full
Operating cash flow$15.1M+67.0%
CapEx$2.8M+101%
Free cash flow$12.3M+60.8%

Valuation

See full
Market cap$2.1B+31.4%
Enterprise value$2.1B+31.6%
P/E33.7×-1.7×
P/S8.2×+1.1×

Profitability

See full
Gross margin72.4%+3.6pp
Operating margin28.5%+5.1pp
Net margin24.3%+4.4pp
FCF margin30.9%+12.7pp

Returns & leverage

See full
Return on equity16.5%+2.8pp
Debt / equity0.1×0.0×
Current ratio14.3×-2.2×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's preferred stock.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LeMaitre Vascular's preferred stock?
LeMaitre Vascular (LMAT) reported preferred stock of $0 in Q1 2026.
What does preferred stock mean?
Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.